Ulcerative colitis and Crohn's disease are the principal forms of inflammatory bowel disease.
Both represent chronic inflammation of the gastrointestinal tract, which displays …

Background There is an increasing body of evidence showing that earlier use of biologics
improves clinical outcomes in Crohn's disease (CD). Aim To perform a systematic review …

Crohn's disease is an idiopathic inflammatory disorder of unknown etiology with genetic,
immunologic, and environmental influences. The incidence of Crohn's disease has steadily …

Abstract Background and Aims: The efficacy of azathioprine for Crohn's disease under
adalimumab treatment remains obscure. Methods: In an open-labelled prospective study …

Guidelines for clinical practice are intended to suggest preferable approaches to particular
medical problems as established by interpretation and collation of scientifically valid …

Aims Exclusive enteral nutrition [EEN] is as efficacious as corticosteroids [CS] to induce
remission in Crohn's disease [CD], without their adverse effects. EEN seems to be more …

Inflammatory bowel disease (IBD) presents with disabling symptoms and may lead to
insufficient growth and late pubertal development in cases of disease onset during …

Abstract Background: Exclusive Enteral Nutrition (EEN) induction in children with luminal
Crohn's disease (CD) gives early mucosal healing (MH), but the long-term benefits of EEN …

Background & Aims We evaluated the impact of immunosuppressants (IS) and anti–tumor
necrosis factor (TNF) introduction on Crohn's disease (CD) long-term outcomes in a large …

Background The role of therapeutic drug monitoring for infliximab [IFX] therapy in children
with inflammatory bowel disease [IBD] is poorly investigated. We determined if IFX exposure …